Imatinib mesilate for the treatment of gastrointestinal stromal tumour

Author： Cassier Philippe A   Dufresne Armelle   Arifi Samia   Sayadi Hiba El   Labidi Intidar   Ray-Coquard Isabelle   Tabone Séverine   Méeus Pierre   Ranchère Dominique   Sunyach Marie-Pierre   Decouvelaere Anne-Valérie   Alberti Laurent   Blay Jean-Yves  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.7, 2008-05, pp. : 1211-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib mesylate in the treatment of gastrointestinal stromal tumour

By Steinert Dejka M   McAuliffe John C   Trent Jonathan C  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 105-113

Informa Healthcare

Access to resources Recommend Favorite

Imatinib: As Adjuvant Therapy for Gastrointestinal Stromal Tumour

By Sanford Mark   Scott Lesley J.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1963-1972

Adis International

Access to resources Recommend Favorite

Imatinib Mesylate: In the Treatment of Gastrointestinal Stromal Tumours

By Croom K.F.   Perry C.M.  

Drugs, Vol. 63, Iss. 5, 2003-01 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?

By Nilsson Bengt   Nilsson Ola   Ahlman Håkan  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 457-468

Informa Healthcare

Access to resources Recommend Favorite

Imatinib: Calcification in peritoneal implants in a patient with gastrointestinal stromal tumour: case report

By  

Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite